Sandoz Group AG (SDZNY)
OTCMKTS · Delayed Price · Currency is USD
61.15
+0.05 (0.07%)
Oct 17, 2025, 2:05 PM EDT
Sandoz Group AG Revenue
Sandoz Group AG had revenue of $5.27 billion in the half year ending June 30, 2025, with 6.80% growth. This brings the company's revenue in the last twelve months to $10.59 billion, up 4.71% year-over-year. In the year 2024, Sandoz Group AG had annual revenue of $10.38 billion with 4.06% growth.
Revenue (ttm)
10.59B
Revenue Growth
+4.71%
P/S Ratio
2.49
Revenue / Employee
529.35K
Employees
22,049
Market Cap
26.32B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 10.38B | 405.00M | 4.06% |
Dec 31, 2023 | 9.98B | 673.00M | 7.23% |
Dec 31, 2022 | 9.31B | -372.00M | -3.84% |
Dec 31, 2021 | 9.68B | 20.00M | 0.21% |
Dec 31, 2020 | 9.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
American Oncology Network | 1.76B |
Veradigm | 588.02M |
Jushi Holdings | 256.36M |
Glass House Brands | 221.55M |
Elite Pharmaceuticals | 105.45M |
Silence Therapeutics | 27.17M |
Nuo Therapeutics | 1.95M |
Northwest Biotherapeutics | 1.09M |
Sandoz Group AG News
- 7 days ago - FDA Gives Tentative Nod to Sandoz's Generic Version of Pfizer's Inlyta - GuruFocus
- 7 days ago - Sandoz granted tentative approval for generic of Pfizer's Inlyta - Seeking Alpha
- 11 days ago - My Top 5 Biotech Stocks Big Pharma Could Buy Next - Seeking Alpha
- 23 days ago - Sandoz launches affordable iron sucrose injection for treatment of iron deficiency anemia in patients with chronic kidney disease in US - Business Wire
- 5 weeks ago - Regeneron (REGN) Reaches Settlement with Sandoz Over Eylea Biosimilar - GuruFocus
- 7 weeks ago - Sandoz welcomes Quebec government support for Boucherville plant modernization project - Benzinga
- 2 months ago - Lupin partners with Sandoz to commercialize Ranibizumab biosimilar in multiple global markets - Business Upturn
- 2 months ago - Sandoz launches renewable energy partnership to cover nearly 90% of electricity demand for European operations - GlobeNewsWire